nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC22A5—Dactinomycin—uterine cancer	0.612	1	CbGbCtD
Cefixime—Pruritus genital—Progesterone—uterine cancer	0.0136	0.0408	CcSEcCtD
Cefixime—Cholestasis—Progesterone—uterine cancer	0.00746	0.0224	CcSEcCtD
Cefixime—Vaginal inflammation—Progesterone—uterine cancer	0.00566	0.017	CcSEcCtD
Cefixime—Vaginal infection—Progesterone—uterine cancer	0.00535	0.0161	CcSEcCtD
Cefixime—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.0154	CcSEcCtD
Cefixime—Nephropathy toxic—Etoposide—uterine cancer	0.00504	0.0152	CcSEcCtD
Cefixime—SLC15A1—epithelium—uterine cancer	0.00489	0.0885	CbGeAlD
Cefixime—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.0146	CcSEcCtD
Cefixime—Hepatic function abnormal—Progesterone—uterine cancer	0.0047	0.0141	CcSEcCtD
Cefixime—SLC15A1—renal system—uterine cancer	0.00454	0.0821	CbGeAlD
Cefixime—SLC15A1—endometrium—uterine cancer	0.00439	0.0794	CbGeAlD
Cefixime—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00426	0.0128	CcSEcCtD
Cefixime—Anaphylactoid reaction—Progesterone—uterine cancer	0.00425	0.0128	CcSEcCtD
Cefixime—SLC15A1—mammalian vulva—uterine cancer	0.00424	0.0768	CbGeAlD
Cefixime—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00413	0.0124	CcSEcCtD
Cefixime—Face oedema—Progesterone—uterine cancer	0.00397	0.0119	CcSEcCtD
Cefixime—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.0116	CcSEcCtD
Cefixime—Aplastic anaemia—Dactinomycin—uterine cancer	0.00376	0.0113	CcSEcCtD
Cefixime—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.0108	CcSEcCtD
Cefixime—SLC22A5—myometrium—uterine cancer	0.00339	0.0613	CbGeAlD
Cefixime—SLC15A1—vagina—uterine cancer	0.00329	0.0595	CbGeAlD
Cefixime—Lactic dehydrogenase activity increased—Epirubicin—uterine cancer	0.00317	0.00954	CcSEcCtD
Cefixime—Jaundice—Progesterone—uterine cancer	0.00309	0.00928	CcSEcCtD
Cefixime—Urinary tract infection—Progesterone—uterine cancer	0.00308	0.00926	CcSEcCtD
Cefixime—Body temperature increased—Carboplatin—uterine cancer	0.00304	0.00914	CcSEcCtD
Cefixime—SLC15A2—uterine cervix—uterine cancer	0.00303	0.0549	CbGeAlD
Cefixime—Lactic dehydrogenase activity increased—Doxorubicin—uterine cancer	0.00294	0.00883	CcSEcCtD
Cefixime—Haemoglobin—Progesterone—uterine cancer	0.00286	0.00859	CcSEcCtD
Cefixime—Hepatitis—Progesterone—uterine cancer	0.00284	0.00855	CcSEcCtD
Cefixime—Haemorrhage—Progesterone—uterine cancer	0.00284	0.00855	CcSEcCtD
Cefixime—SLC15A2—renal system—uterine cancer	0.00284	0.0513	CbGeAlD
Cefixime—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.00841	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Epirubicin—uterine cancer	0.00279	0.0084	CcSEcCtD
Cefixime—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00279	0.00839	CcSEcCtD
Cefixime—Candida infection—Etoposide—uterine cancer	0.00277	0.00832	CcSEcCtD
Cefixime—SLC15A2—endometrium—uterine cancer	0.00274	0.0496	CbGeAlD
Cefixime—Erythema multiforme—Progesterone—uterine cancer	0.00269	0.00808	CcSEcCtD
Cefixime—SLC22A5—uterine cervix—uterine cancer	0.00264	0.0477	CbGeAlD
Cefixime—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00262	0.00787	CcSEcCtD
Cefixime—Thrombocytosis—Epirubicin—uterine cancer	0.00261	0.00785	CcSEcCtD
Cefixime—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.00779	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Doxorubicin—uterine cancer	0.00259	0.00777	CcSEcCtD
Cefixime—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00775	CcSEcCtD
Cefixime—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00775	CcSEcCtD
Cefixime—SLC22A5—renal system—uterine cancer	0.00247	0.0446	CbGeAlD
Cefixime—Flatulence—Progesterone—uterine cancer	0.00244	0.00733	CcSEcCtD
Cefixime—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00733	CcSEcCtD
Cefixime—Thrombocytosis—Doxorubicin—uterine cancer	0.00242	0.00726	CcSEcCtD
Cefixime—SLC22A5—endometrium—uterine cancer	0.00239	0.0432	CbGeAlD
Cefixime—Pancytopenia—Dactinomycin—uterine cancer	0.00239	0.00717	CcSEcCtD
Cefixime—Neutropenia—Dactinomycin—uterine cancer	0.00235	0.00706	CcSEcCtD
Cefixime—SLC15A2—female reproductive system—uterine cancer	0.00227	0.0411	CbGeAlD
Cefixime—Angioedema—Progesterone—uterine cancer	0.00226	0.0068	CcSEcCtD
Cefixime—Blister—Epirubicin—uterine cancer	0.00225	0.00677	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00222	0.00667	CcSEcCtD
Cefixime—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00665	CcSEcCtD
Cefixime—Anaphylactoid reaction—Etoposide—uterine cancer	0.00217	0.00653	CcSEcCtD
Cefixime—Convulsion—Progesterone—uterine cancer	0.00215	0.00645	CcSEcCtD
Cefixime—Agranulocytosis—Dactinomycin—uterine cancer	0.00209	0.00628	CcSEcCtD
Cefixime—Blister—Doxorubicin—uterine cancer	0.00208	0.00627	CcSEcCtD
Cefixime—SLC15A2—female gonad—uterine cancer	0.00207	0.0374	CbGeAlD
Cefixime—SLC15A2—vagina—uterine cancer	0.00206	0.0372	CbGeAlD
Cefixime—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00616	CcSEcCtD
Cefixime—Anaphylactic shock—Progesterone—uterine cancer	0.00202	0.00607	CcSEcCtD
Cefixime—Hepatitis—Dactinomycin—uterine cancer	0.00201	0.00604	CcSEcCtD
Cefixime—Shock—Progesterone—uterine cancer	0.00199	0.00598	CcSEcCtD
Cefixime—SLC22A5—female reproductive system—uterine cancer	0.00198	0.0358	CbGeAlD
Cefixime—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00584	CcSEcCtD
Cefixime—Erythema multiforme—Dactinomycin—uterine cancer	0.0019	0.00571	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00189	0.00569	CcSEcCtD
Cefixime—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0055	CcSEcCtD
Cefixime—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00542	CcSEcCtD
Cefixime—SLC22A5—female gonad—uterine cancer	0.0018	0.0325	CbGeAlD
Cefixime—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00539	CcSEcCtD
Cefixime—SLC22A5—vagina—uterine cancer	0.00179	0.0323	CbGeAlD
Cefixime—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00179	0.00537	CcSEcCtD
Cefixime—Dyspepsia—Progesterone—uterine cancer	0.00178	0.00535	CcSEcCtD
Cefixime—Pancytopenia—Etoposide—uterine cancer	0.00173	0.00519	CcSEcCtD
Cefixime—Blood bilirubin increased—Epirubicin—uterine cancer	0.00172	0.00516	CcSEcCtD
Cefixime—Neutropenia—Etoposide—uterine cancer	0.0017	0.00511	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00165	0.00497	CcSEcCtD
Cefixime—Gastrointestinal pain—Progesterone—uterine cancer	0.00165	0.00497	CcSEcCtD
Cefixime—Vaginal inflammation—Epirubicin—uterine cancer	0.00162	0.00488	CcSEcCtD
Cefixime—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00485	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00161	0.00483	CcSEcCtD
Cefixime—Urticaria—Progesterone—uterine cancer	0.00161	0.00483	CcSEcCtD
Cefixime—Abdominal pain—Progesterone—uterine cancer	0.0016	0.0048	CcSEcCtD
Cefixime—Body temperature increased—Progesterone—uterine cancer	0.0016	0.0048	CcSEcCtD
Cefixime—Renal failure—Etoposide—uterine cancer	0.00159	0.00479	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—uterine cancer	0.00159	0.00478	CcSEcCtD
Cefixime—Jaundice—Etoposide—uterine cancer	0.00158	0.00475	CcSEcCtD
Cefixime—Leukopenia—Dactinomycin—uterine cancer	0.00157	0.00471	CcSEcCtD
Cefixime—Colitis—Epirubicin—uterine cancer	0.00156	0.00469	CcSEcCtD
Cefixime—Candida infection—Epirubicin—uterine cancer	0.00155	0.00466	CcSEcCtD
Cefixime—Vaginal infection—Epirubicin—uterine cancer	0.00153	0.00461	CcSEcCtD
Cefixime—Aplastic anaemia—Epirubicin—uterine cancer	0.00152	0.00458	CcSEcCtD
Cefixime—Agranulocytosis—Etoposide—uterine cancer	0.00151	0.00455	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—uterine cancer	0.0015	0.00452	CcSEcCtD
Cefixime—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.0045	CcSEcCtD
Cefixime—Hypersensitivity—Progesterone—uterine cancer	0.00149	0.00448	CcSEcCtD
Cefixime—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00437	CcSEcCtD
Cefixime—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00435	CcSEcCtD
Cefixime—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00435	CcSEcCtD
Cefixime—Colitis—Doxorubicin—uterine cancer	0.00144	0.00434	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—uterine cancer	0.00143	0.00431	CcSEcCtD
Cefixime—Pruritus—Progesterone—uterine cancer	0.00143	0.0043	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—uterine cancer	0.00142	0.00427	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—uterine cancer	0.00141	0.00424	CcSEcCtD
Cefixime—Thrombocytopenia—Dactinomycin—uterine cancer	0.0014	0.0042	CcSEcCtD
Cefixime—Diarrhoea—Progesterone—uterine cancer	0.00138	0.00416	CcSEcCtD
Cefixime—Erythema multiforme—Etoposide—uterine cancer	0.00138	0.00414	CcSEcCtD
Cefixime—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00406	CcSEcCtD
Cefixime—Hepatic function abnormal—Epirubicin—uterine cancer	0.00135	0.00406	CcSEcCtD
Cefixime—Dizziness—Progesterone—uterine cancer	0.00134	0.00402	CcSEcCtD
Cefixime—SLC15A2—lymph node—uterine cancer	0.00133	0.024	CbGeAlD
Cefixime—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00389	CcSEcCtD
Cefixime—Vomiting—Progesterone—uterine cancer	0.00128	0.00386	CcSEcCtD
Cefixime—Renal failure acute—Epirubicin—uterine cancer	0.00128	0.00384	CcSEcCtD
Cefixime—Rash—Progesterone—uterine cancer	0.00127	0.00383	CcSEcCtD
Cefixime—Dermatitis—Progesterone—uterine cancer	0.00127	0.00383	CcSEcCtD
Cefixime—Headache—Progesterone—uterine cancer	0.00127	0.00381	CcSEcCtD
Cefixime—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00377	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00125	0.00375	CcSEcCtD
Cefixime—Renal impairment—Epirubicin—uterine cancer	0.00124	0.00372	CcSEcCtD
Cefixime—Dermatitis bullous—Epirubicin—uterine cancer	0.00123	0.00371	CcSEcCtD
Cefixime—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00122	0.00366	CcSEcCtD
Cefixime—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00364	CcSEcCtD
Cefixime—Nausea—Progesterone—uterine cancer	0.0012	0.00361	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—uterine cancer	0.00118	0.00355	CcSEcCtD
Cefixime—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00117	0.00351	CcSEcCtD
Cefixime—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.0035	CcSEcCtD
Cefixime—SLC22A5—lymph node—uterine cancer	0.00116	0.0209	CbGeAlD
Cefixime—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00347	CcSEcCtD
Cefixime—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00347	CcSEcCtD
Cefixime—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00345	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—uterine cancer	0.00115	0.00345	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—uterine cancer	0.00114	0.00343	CcSEcCtD
Cefixime—Face oedema—Epirubicin—uterine cancer	0.00114	0.00342	CcSEcCtD
Cefixime—Leukopenia—Etoposide—uterine cancer	0.00113	0.00341	CcSEcCtD
Cefixime—Body temperature increased—Dactinomycin—uterine cancer	0.00113	0.00339	CcSEcCtD
Cefixime—Abdominal pain—Dactinomycin—uterine cancer	0.00113	0.00339	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00113	0.00339	CcSEcCtD
Cefixime—Convulsion—Etoposide—uterine cancer	0.0011	0.0033	CcSEcCtD
Cefixime—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00327	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00106	0.00319	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—uterine cancer	0.00105	0.00317	CcSEcCtD
Cefixime—Hypersensitivity—Dactinomycin—uterine cancer	0.00105	0.00316	CcSEcCtD
Cefixime—Anaphylactic shock—Etoposide—uterine cancer	0.00103	0.00311	CcSEcCtD
Cefixime—Thrombocytopenia—Etoposide—uterine cancer	0.00101	0.00304	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—uterine cancer	0.00101	0.00303	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000982	0.00295	CcSEcCtD
Cefixime—Diarrhoea—Dactinomycin—uterine cancer	0.000977	0.00294	CcSEcCtD
Cefixime—Pancytopenia—Epirubicin—uterine cancer	0.000968	0.00291	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—uterine cancer	0.000953	0.00286	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—uterine cancer	0.000933	0.00281	CcSEcCtD
Cefixime—Vomiting—Dactinomycin—uterine cancer	0.000908	0.00273	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000901	0.00271	CcSEcCtD
Cefixime—Rash—Dactinomycin—uterine cancer	0.000901	0.00271	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—uterine cancer	0.000895	0.00269	CcSEcCtD
Cefixime—Renal failure—Epirubicin—uterine cancer	0.000893	0.00268	CcSEcCtD
Cefixime—Jaundice—Epirubicin—uterine cancer	0.000886	0.00266	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—uterine cancer	0.000883	0.00265	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—uterine cancer	0.000882	0.00265	CcSEcCtD
Cefixime—Nausea—Dactinomycin—uterine cancer	0.000848	0.00255	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—uterine cancer	0.000848	0.00255	CcSEcCtD
Cefixime—Gastrointestinal pain—Etoposide—uterine cancer	0.000845	0.00254	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000833	0.00251	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—uterine cancer	0.000826	0.00248	CcSEcCtD
Cefixime—Urticaria—Etoposide—uterine cancer	0.000821	0.00247	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—uterine cancer	0.00082	0.00246	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—uterine cancer	0.000819	0.00246	CcSEcCtD
Cefixime—Body temperature increased—Etoposide—uterine cancer	0.000817	0.00246	CcSEcCtD
Cefixime—Abdominal pain—Etoposide—uterine cancer	0.000817	0.00246	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—uterine cancer	0.000817	0.00246	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—uterine cancer	0.000816	0.00245	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—uterine cancer	0.000816	0.00245	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—uterine cancer	0.000784	0.00236	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—uterine cancer	0.000771	0.00232	CcSEcCtD
Cefixime—Hypersensitivity—Etoposide—uterine cancer	0.000762	0.00229	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—uterine cancer	0.000758	0.00228	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—uterine cancer	0.000755	0.00227	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—uterine cancer	0.000755	0.00227	CcSEcCtD
Cefixime—Pruritus—Etoposide—uterine cancer	0.000731	0.0022	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—uterine cancer	0.000714	0.00215	CcSEcCtD
Cefixime—Diarrhoea—Etoposide—uterine cancer	0.000707	0.00213	CcSEcCtD
Cefixime—Flatulence—Epirubicin—uterine cancer	0.0007	0.0021	CcSEcCtD
Cefixime—Dizziness—Etoposide—uterine cancer	0.000684	0.00205	CcSEcCtD
Cefixime—Vomiting—Etoposide—uterine cancer	0.000657	0.00198	CcSEcCtD
Cefixime—Rash—Etoposide—uterine cancer	0.000652	0.00196	CcSEcCtD
Cefixime—Dermatitis—Etoposide—uterine cancer	0.000651	0.00196	CcSEcCtD
Cefixime—Headache—Etoposide—uterine cancer	0.000648	0.00195	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—uterine cancer	0.000647	0.00195	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—uterine cancer	0.000636	0.00191	CcSEcCtD
Cefixime—Convulsion—Epirubicin—uterine cancer	0.000615	0.00185	CcSEcCtD
Cefixime—Nausea—Etoposide—uterine cancer	0.000614	0.00185	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—uterine cancer	0.000588	0.00177	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—uterine cancer	0.000579	0.00174	CcSEcCtD
Cefixime—Shock—Epirubicin—uterine cancer	0.00057	0.00171	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—uterine cancer	0.000569	0.00171	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—uterine cancer	0.000567	0.00171	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—uterine cancer	0.000536	0.00161	CcSEcCtD
Cefixime—Shock—Doxorubicin—uterine cancer	0.000527	0.00159	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—uterine cancer	0.000525	0.00158	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—uterine cancer	0.00051	0.00153	CcSEcCtD
Cefixime—Gastrointestinal pain—Epirubicin—uterine cancer	0.000474	0.00142	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—uterine cancer	0.000472	0.00142	CcSEcCtD
Cefixime—Urticaria—Epirubicin—uterine cancer	0.00046	0.00138	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—uterine cancer	0.000458	0.00138	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—uterine cancer	0.000458	0.00138	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000438	0.00132	CcSEcCtD
Cefixime—Hypersensitivity—Epirubicin—uterine cancer	0.000427	0.00128	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—uterine cancer	0.000426	0.00128	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—uterine cancer	0.000424	0.00127	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—uterine cancer	0.000424	0.00127	CcSEcCtD
Cefixime—Pruritus—Epirubicin—uterine cancer	0.00041	0.00123	CcSEcCtD
Cefixime—Diarrhoea—Epirubicin—uterine cancer	0.000396	0.00119	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—uterine cancer	0.000395	0.00119	CcSEcCtD
Cefixime—Dizziness—Epirubicin—uterine cancer	0.000383	0.00115	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—uterine cancer	0.000379	0.00114	CcSEcCtD
Cefixime—Vomiting—Epirubicin—uterine cancer	0.000368	0.00111	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—uterine cancer	0.000367	0.0011	CcSEcCtD
Cefixime—Rash—Epirubicin—uterine cancer	0.000365	0.0011	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—uterine cancer	0.000365	0.0011	CcSEcCtD
Cefixime—Headache—Epirubicin—uterine cancer	0.000363	0.00109	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—uterine cancer	0.000355	0.00107	CcSEcCtD
Cefixime—Nausea—Epirubicin—uterine cancer	0.000344	0.00103	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—uterine cancer	0.000341	0.00102	CcSEcCtD
Cefixime—Rash—Doxorubicin—uterine cancer	0.000338	0.00102	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—uterine cancer	0.000338	0.00102	CcSEcCtD
Cefixime—Headache—Doxorubicin—uterine cancer	0.000336	0.00101	CcSEcCtD
Cefixime—Nausea—Doxorubicin—uterine cancer	0.000318	0.000957	CcSEcCtD
